Clark Paul N
SEC-identified person · CIK 1222248 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Antigenics INC /DE/ agend | Director | filed 2020 - 2021 |
| Keysight Technologies, Inc. KEYS | Director | filed 2014 - 2021 |
| Agilent Technologies, INC. A | Director | filed 2006 - 2021 |
| Biolase, INC BLTI | Director | filed 2014 - 2017 |
| Amylin Pharmaceuticals INC AMLN | Director | filed 2009 - 2012 |
| Talecris Biotherapeutics Holdings Corp. v9sns*ij | Director | filed 2009 - 2011 |
| Icos Corp ICOS | Director · Chairman, CEO & President | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.